FDA Advisory Panel Rejects Novel ALS Drug
A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.
Source: medscape.com
Stay updated with breaking news from Accurate Rest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.